Low-dose carbon monoxide inhibits progressive chronic allograft nephropathy and restores renal allograft function.
Low-dose carbon monoxide inhibits progressive chronic allograft nephropathy and restores renal allograft function.
复制标题
低剂量一氧化碳可抑制进行性慢性同种异体移植肾病并恢复同种异体移植肾功能。
DOI:
10.1152/ajprenal.90728.2008
复制
发表时间:
2009
期刊:
影响因子:
--
通讯作者:
Murase,Noriko
中科院分区:
文献类型:
--
作者:
Nakao,Atsunori;Faleo,Gaetano;Nalesnik,MichaelA;Seda-Neto,Joao;Kohmoto,Junichi;Murase,Noriko
Chronic allograft nephropathy (CAN) represents progressive deterioration of renal allograft function with fibroinflammatory changes. CAN, recently reclassified as interstitial fibrosis (IF) and tubular atrophy (TA) with no known specific etiology, is a major cause of late renal allograft loss and remains a significant deleterious factor of successful renal transplantation. Carbon monoxide (CO), an effector byproduct of heme oxygenase pathway, is known to have potent anti-inflammatory and antifibrotic functions. We hypothesized that inhaled CO would inhibit fibroinflammatory process of CAN and restore renal allograft function, even when the treatment was initiated after CAN was established. Lewis rat kidney grafts were orthotopically transplanted into binephrectomized allogenic Brown Norway rats under brief tacrolimus (0.5 mg/kg im,days 0–6). Atday 60, CO (20 ppm) inhalation was initiated to recipients and continued untilday 150or animal death. Development of CAN was confirmed atday 60with decreased creatinine clearance (CCr), significant proteinuria, and histopathological findings of TA, IF, and intimal arteritis. Air-treated control recipients continued to deteriorate with further declines of CCr and increases of urinary protein excretion and died with a median survival of 82 days. In contrast, progression of CAN was decelerated when recipients received CO ondays 60–150, showing markedly improved graft histopathology, restored renal function, and improved recipient survival to a median of >150 days. CO significantly reduced intragraft mRNA levels for IFN-γ and TNF-α atday 90. Expression of profibrotic TGF-β/Smad was significantly suppressed with CO, together with downregulation of ERK-MAPK pathways. Continuous CO (20 ppm) treatment fordays 0–30,days 30–60, ordays 0–90, or daily 1-h CO (250 ppm) treatment fordays 0–90, also showed efficacy in inhibiting CAN. The study demonstrates that CO is able to inhibit progression of fibroinflammatory process of CAN, restore renal allograft function, and improve survival even when the treatment is started after CAN is diagnosed.
登录
查看更多内容
DOI:
10.1016/j.bbrc.2006.03.058
发表时间:
2006-05-12
影响因子:
3.1
作者:
Lee, BS;Heo, J;Chung, HT
通讯作者:
Chung, HT
影响因子:
6
作者:
M. Zhang;D. Fraser;A. Phillips
通讯作者:
A. Phillips
影响因子:
56.9
作者:
VERMA, A;HIRSCH, DJ;SNYDER, SH
通讯作者:
SNYDER, SH
影响因子:
6
作者:
Nakao, A;Kimizuka, K;Murase, N
通讯作者:
Murase, N
影响因子:
8.8
作者:
J. Tyler;H. Robertson;T. Booth;Alastair D. Burt;John A. Kirby
通讯作者:
John A. Kirby